Viking Therapeutics, Inc. License Agreements
6 Contracts & Agreements
- Second Amendment to Master License Agreement, dated April 8, 2015, by and among Viking Therapeutics, Inc., Ligand Pharmaceuticals Incorporated and Metabasis Therapeutics, Inc (Filed With SEC on July 24, 2024)
- First Amendment to Master License Agreement, dated September 6, 2014, by and among Viking Therapeutics, Inc., Ligand Pharmaceuticals Incorporated and Metabasis Therapeutics, Inc (Filed With SEC on July 24, 2024)
- Master License Agreement, dated May 21, 2014, by and among Viking Therapeutics, Inc., Ligand Pharmaceuticals Incorporated and Metabasis Therapeutics, Inc (Filed With SEC on July 24, 2024)
- SECOND AMENDMENT TO MASTER LICENSE AGREEMENT (Filed With SEC on April 10, 2015)
- First AmendmentTo Master License Agreement (Filed With SEC on September 8, 2014)
- MASTER LICENSEAGREEMENT Dated May 21, 2014 by and between LigandPharmaceuticals Incorporated and Metabasis Therapeutics, Inc., on one hand, and Viking Therapeutics, Inc., on the... (Filed With SEC on July 1, 2014)
